Rating History for Horizon Therapeutics (HZNP) by Stifel
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/12/2022 | Annabel Samimy | Downgrade | Hold (Buy) |
116.50 (138.00) |
97.29 (116.30) |
19.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/12/2022 | Annabel Samimy | Downgrade | Hold (Buy) |
116.50 (138.00) |
97.29 (116.30) |
19.54% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||